Document Detail

Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
MedLine Citation:
PMID:  15791658     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To examine whether second-trimester maternal serum triple marker screening results differ between in vitro fertilization (IVF) pregnancies and naturally conceived pregnancies. METHODS: Second-trimester maternal serum triple marker screening results from 88 IVF pregnancies were compared with 596 naturally conceived pregnancies (controls). Controls were matched to each IVF pregnancy by maternal age, gestational age and date of blood collection. All pregnancies in the study were known to have normal outcome. Multiple of the median (MoM) levels of human chorionic gonadotrophin (hCG), unconjugated estriol (uE3) and alpha-fetoprotein (AFP), and the false-positive rate for Down syndrome were compared between the two groups. RESULTS: No statistically significant differences in analyte levels or in Down syndrome false-positive rate were observed between the IVF and naturally conceived pregnancies. CONCLUSION: IVF patients can be counselled about maternal serum triple marker screening in the same manner as patients with naturally conceived pregnancies. There is no evidence to support the general use of analyte correction factors in the interpretation of second-trimester maternal serum screen results in IVF pregnancies.
Jennifer D Rice; Sarah F McIntosh; Anne C Halstead
Related Documents :
17141768 - Utility of screening for other causes of infertility in women with "known" polycystic o...
10584618 - Urinary tract infections in pregnancy.
8544548 - Prenatal screening for cystic fibrosis: 5 years' experience reviewed.
1655058 - Screening pregnant women for genital herpes.
17451978 - Subclinical mastitis changes the patterns of maternal-offspring behaviour in dairy sheep.
25097428 - Retrospective study of risk factors and maternal and fetal outcome in patients with abr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  25     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-04-04     Completed Date:  2005-08-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  234-8     Citation Subset:  IM    
Copyright Information:
Copyright 2005 John Wiley & Sons, Ltd.
Department of Medical Genetics, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers
Chorionic Gonadotropin / blood*
Down Syndrome / blood*,  diagnosis*
Estriol / blood*
Fertilization in Vitro*
Fetal Diseases / diagnosis*
Mass Screening
Pregnancy Trimester, Second
alpha-Fetoproteins / analysis*
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin; 0/alpha-Fetoproteins; 50-27-1/Estriol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Magnetic resonance image findings of placental lake: report of two cases.
Next Document:  Prenatally detected trisomy 20 mosaicism.